Cell Biosciences, Inc., a Santa Clara, CA-based life science company, raised $4m in an equity financing led by Novo A/S.
The company has also acquired Protein Forest, Inc. a Lexington, Massachusetts-based developer of a sample preparation technology for proteomic analysis and biomarker discovery.
Cell Biosciences develops instrumentation systems, sample preparation systems, software and assay products for proteomic and genomic research. The all-stock acquisition adds Protein Forest’s novel digital ProteomeChip(TM) product line to the company’s expanding portfolio of innovative products for protein analysis.
Cell Biosciences has approximately 100 employees in North America, Europe and Asia, and its products are sold in more than 40 countries.